Richard O Cannon's Web Page

(Please use Microsoft Internet Explorer version 6.0 or higher to run this application)

Publications

1 Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO, Wang Y, Katz A, Levine M, Quon MJ.
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.
Am J Physiol Heart Circ Physiol 290(1): H137-45, 2006. [Text Abstract on PubMed]
2 Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR, Feelisch M, Lundberg JO.
Corrigendum: The emerging biology of the nitrite anion.
Nat Chem Biol 2(2): 110, 2006. [Text Abstract on PubMed]
3 Bussey HI, Tapson V, Cannon RO, Nolan PE, Gage B, Penzak SR, Spinler SA, De Smet P, Wittkowsky A, Lee AP, Ernst E, Marder VJ.
Opinions and research priorities.
Thromb Res 117(1-2): 155-69; discussion 170-4, 2005. [Text Abstract on PubMed]
4 Cannon RO.
Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction.
Nat Clin Pract Cardiovasc Med 2(2): 88-94, 2005. [Text Abstract on PubMed]
5 Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR, Feelisch M, Lundberg JO.
The emerging biology of the nitrite anion.
Nat Chem Biol 1(6): 308-14, 2005. [Text Abstract on PubMed]
6 Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, Read EJ, Khuu HM, Leitman SF, Horne M, Csako G, Dunbar CE, Waclawiw MA, Cannon RO.
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.
J Am Coll Cardiol 46(9): 1643-8, 2005. [Text Abstract on PubMed]
7 McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA, .
Search for predictors of nontherapeutic INR results with warfarin therapy.
Ann Pharmacother 39(12): 1996-2002, 2005. [Text Abstract on PubMed]
8 Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, Finkel T, Cannon RO.
Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
Arterioscler Thromb Vasc Biol 25(2): 296-301, 2005. [Text Abstract on PubMed]
9 Syed MA, Paterson DI, Ingkanisorn WP, Rhoads KL, Hill J, Cannon RO, Arai AE.
Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research.
J Cardiovasc Magn Reson 7(5): 763-8, 2005. [Text Abstract on PubMed]
10 Cannon RO.
Cardiovascular potential of BM-derived stem and progenitor cells.
Cytotherapy 6(6): 602-7, 2004. [Text Abstract on PubMed]
11 Kim-Shapiro DB, Patel RP, Schechter AN, Gladwin MT, Cannon RO, Hogg N.
How do red blood cells dilate blood vessels?--Reply.
Circ Res 95(3): e10, 2004. [Text Abstract on PubMed]
12 Smith SC, Anderson JL, Cannon RO, Fadl YY, Koenig W, Libby P, Lipshultz SE, Mensah GA, Ridker PM, Rosenson R, , .
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
Circulation 110(25): e550-3, 2004. [Text Abstract on PubMed]
13 Cannon RO.
Assessing risk in hypertrophic cardiomyopathy.
N Engl J Med 349(11): 1016-8, 2003. [Text Abstract on PubMed]
14 Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, Gladwin MT.
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.
Nat Med 9(12): 1498-505, 2003. [Text Abstract on PubMed]
15 Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Divergent nitric oxide bioavailability in men and women with sickle cell disease.
Circulation 107(2): 271-8, 2003. [Text Abstract on PubMed]
16 Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F, , .
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Circulation 107(3): 499-511, 2003. [Text Abstract on PubMed]
17 Zuzak KJ, Gladwin MT, Cannon RO, Levin IW.
Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.
Am J Physiol Heart Circ Physiol 285(3): H1183-9, 2003. [Text Abstract on PubMed]
18 Bui MN, Arai AE, Hathaway L, Waclawiw MA, Csako G, Cannon RO.
Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women.
Am J Cardiol 90(1): 82-5, 2002. [Text Abstract on PubMed]
19 Cannon RO.
Oral L-arginine (and other active ingredients) for ischemic heart disease?.
J Am Coll Cardiol 39(1): 46-8, 2002. [Text Abstract on PubMed]
20 Cannon RO.
Restenosis after angioplasty.
N Engl J Med 346(16): 1182-3, 2002. [Text Abstract on PubMed]
21 Goldstein DS, Holmes C, Frank SM, Dendi R, Cannon RO, Sharabi Y, Esler MD, Eisenhofer G.
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Circulation 106(18): 2358-65, 2002. [Text Abstract on PubMed]
22 Horne MK, McCloskey DJ, Cullinane AM, Merryman PK, Rick ME, Hortin GL, Waclawiw MA, Cannon RO.
Parameters of coagulant and fibrinolytic capacity and activity in postmenopausal women: within-subject variability.
Thromb Res 107(5): 229-33, 2002. [Text Abstract on PubMed]
23 Koh KK, Schenke WH, Waclawiw MA, Csako G, Cannon RO.
Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
Circulation 105(13): 1531-3, 2002. [Text Abstract on PubMed]
24 Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, Schechter AN, Gladwin MT.
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.
Nat Med 8(12): 1383-9, 2002. [Text Abstract on PubMed]
25 Schechter AN, Gladwin MT, Cannon RO.
NO solutions?
J Clin Invest 109(9): 1149-51, 2002. [Text Abstract on PubMed]
26 Wasserman BA, Smith WI, Trout HH, Cannon RO, Balaban RS, Arai AE.
Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results.
Radiology 223(2): 566-73, 2002. [Text Abstract on PubMed]
27 Ardans JA, Blum A, Mangan PR, Wientroub S, Cannon RO, Wahl LM.
Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes.
Arterioscler Thromb Vasc Biol 21(8): 1265-8, 2001. [Text Abstract on PubMed]
28 Blum A, Cannon RO.
l-Arginine for the prevention and treatment of coronary artery disease.
Coron Artery Dis 12(7): 535-9, 2001. [Text Abstract on PubMed]
29 Blum A, Cannon RO.
Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men.
Ann N Y Acad Sci 949: 168-74, 2001. [Text Abstract on PubMed]
30 Cannon RO, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT.
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery.
J Clin Invest 108(2): 279-87, 2001. [Text Abstract on PubMed]
31 Chang R, Cannon RO, Chen CC, Doppman JL, Shawker TH, Mayo DJ, Wood B, Horne MK.
Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity.
J Vasc Interv Radiol 12(2): 247-52, 2001. [Text Abstract on PubMed]
32 Weiss CR, Arai AE, Bui MN, Agyeman KO, Waclawiw MA, Balaban RS, Cannon RO.
Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans.
J Magn Reson Imaging 14(6): 698-704, 2001. [Text Abstract on PubMed]
33 Zuzak KJ, Schaeberle MD, Gladwin MT, Cannon RO, Levin IW.
Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique.
Circulation 104(24): 2905-10, 2001. [Text Abstract on PubMed]
34 Blum A, Cannon RO, Costello R, Schenke WH, Csako G.
Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women.
J Lab Clin Med 135(3): 231-7, 2000. [Text Abstract on PubMed]
35 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men.
Am J Cardiol 85(12): 1491-4; A7, 2000. [Text Abstract on PubMed]
36 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
J Am Coll Cardiol 35(2): 271-6, 2000. [Text Abstract on PubMed]
37 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Oral L-arginine in patients with coronary artery disease on medical management.
Circulation 101(18): 2160-4, 2000. [Text Abstract on PubMed]
38 Blum A, Koh K, Cannon RO.
CME Paper: Hormone Replacement Therapy for Prevention or Treatment of Atherosclerosis in Postmenopausal Women: Promises, Controversies, and Clinical Trials.
Am J Geriatr Cardiol 9(2): 81-88, 2000. [Text Abstract on PubMed]
39 Blum A, Schenke WH, Hathaway L, Mincemoyer R, Csako G, Waclawiw MA, Cannon RO.
Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women.
Am J Cardiol 86(8): 892-5, 2000. [Text Abstract on PubMed]
40 Cannon RO, Balaban RS.
Chest pain in women with normal coronary angiograms.
N Engl J Med 342(12): 885-7, 2000. [Text Abstract on PubMed]
41 Cannon RO.
Cardiovascular benefit of cholesterol-lowering therapy: does improved endothelial vasodilator function matter?
Circulation 102(8): 820-2, 2000. [Text Abstract on PubMed]
42 Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Increased activity of endogenous endothelin in patients with hypercholesterolemia.
J Am Coll Cardiol 36(5): 1483-8, 2000. [Text Abstract on PubMed]
43 Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Hypertension 35(6): 1237-41, 2000. [Text Abstract on PubMed]
44 Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, Ognibene FP, Cannon RO.
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans.
Proc Natl Acad Sci U S A 97(21): 11482-7, 2000. [Text Abstract on PubMed]
45 Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO.
Cardiac sympathetic denervation in Parkinson disease.
Ann Intern Med 133(5): 338-47, 2000. [Text Abstract on PubMed]
46 Horne MK, Mayo DJ, Cannon RO, Chen CC, Shawker TH, Chang R.
Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities.
Am J Med 108(3): 251-5, 2000. [Text Abstract on PubMed]
47 Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO.
Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells.
Circulation 102(24): 2990-6, 2000. [Text Abstract on PubMed]
48 Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO.
Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells.
Circ Res 87(11): 1006-11, 2000. [Text Abstract on PubMed]
49 Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon RO, Quyyumi AA.
Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.
Am J Cardiol 85(12): 1414-9, 2000. [Text Abstract on PubMed]
50 Zanger D, Yang BK, Ardans J, Waclawiw MA, Csako G, Wahl LM, Cannon RO.
Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
J Am Coll Cardiol 36(6): 1797-802, 2000. [Text Abstract on PubMed]
51 Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO, Higano ST, Holmes DR, Lerman A.
Systemic amyloidosis presenting with angina pectoris.
Ann Intern Med 131(11): 838-41, 1999. [Text Abstract on PubMed]
52 Cardillo C, Kilcoyne CM, Waclawiw M, Cannon RO, Panza JA.
Role of endothelin in the increased vascular tone of patients with essential hypertension.
Hypertension 33(2): 753-8, 1999. [Text Abstract on PubMed]
53 Koh KK, Blum A, Hathaway L, Mincemoyer R, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Vascular effects of estrogen and vitamin E therapies in postmenopausal women.
Circulation 100(18): 1851-7, 1999. [Text Abstract on PubMed]
54 Koh KK, Bui MN, Hathaway L, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Mechanism by which quinapril improves vascular function in coronary artery disease.
Am J Cardiol 83(3): 327-31, 1999. [Text Abstract on PubMed]
55 Koh KK, Cardillo C, Bui MN, Hathaway L, Csako G, Waclawiw MA, Panza JA, Cannon RO.
Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.
Circulation 99(3): 354-60, 1999. [Text Abstract on PubMed]
56 Koh KK, Horne MK, Cannon RO.
Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.
Thromb Haemost 82(2): 626-33, 1999. [Text Abstract on PubMed]
57 Koh KK, Horne MK, Csako G, Waclawiw MA, Cannon RO.
Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women.
Am J Cardiol 83(3): 466-9, A10, 1999. [Text Abstract on PubMed]
58 Blum A, Cannon RO.
Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function.
Curr Opin Lipidol 9(6): 575-86, 1998. [Text Abstract on PubMed]
59 Branson BM, Peterman TA, Cannon RO, Ransom R, Zaidi AA.
Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial.
Sex Transm Dis 25(10): 553-60, 1998. [Text Abstract on PubMed]
60 Cannon RO, Curiel RV, Prasad A, Quyyumi AA, Panza JA.
Comparison of coronary endothelial dynamics with electrocardiographic and left ventricular contractile responses to stress in the absence of coronary artery disease.
Am J Cardiol 82(6): 710-4, 1998. [Text Abstract on PubMed]
61 Cannon RO.
Can measures of coronary dynamics explain chest pain without coronary artery disease?
Mayo Clin Proc 73(12): 1226-8, 1998. [Text Abstract on PubMed]
62 Cannon RO.
Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide.
Am J Cardiol 82(10A): 8S-10S, 1998. [Text Abstract on PubMed]
63 Cannon RO.
Role of nitric oxide in cardiovascular disease: focus on the endothelium.
Clin Chem 44(8 Pt 2): 1809-19, 1998. [Text Abstract on PubMed]
64 Cannon RO.
The Conundrum of Cardiovascular Syndrome X.
Cardiol Rev 6(4): 213-220, 1998. [Text Abstract on PubMed]
65 Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients.
J Am Coll Cardiol 32(5): 1207-13, 1998. [Text Abstract on PubMed]
66 Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation.
Hypertension 31(6): 1235-9, 1998. [Text Abstract on PubMed]
67 Cardillo C, Kilcoyne CM, Nambi SS, Cannon RO, Quon MJ, Panza JA.
Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm.
Hypertension 32(4): 740-5, 1998. [Text Abstract on PubMed]
68 Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA.
Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension.
Circulation 97(9): 851-6, 1998. [Text Abstract on PubMed]
69 Goldstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin IJ.
Sympathetic cardioneuropathy in dysautonomias.
Adv Pharmacol 42: 615-9, 1998. [Text Abstract on PubMed]
70 Cannon RO.
Does coronary endothelial dysfunction cause myocardial ischemia in the absence of obstructive coronary artery disease?
Circulation 96(10): 3251-4, 1997. [Text Abstract on PubMed]
71 Cannon RO.
How to manage chest pain in patients with normal coronary angiograms.
Cardiologia 42(1): 21-9, 1997. [Text Abstract on PubMed]
72 Cardillo C, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA.
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients.
Hypertension 30(1 Pt 1): 57-63, 1997. [Text Abstract on PubMed]
73 Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA.
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
Hypertension 30(4): 918-21, 1997. [Text Abstract on PubMed]
74 Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA.
Role of nitric oxide in the vasodilator response to mental stress in normal subjects.
Am J Cardiol 80(8): 1070-4, 1997. [Text Abstract on PubMed]
75 Goldstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin IJ.
Sympathetic cardioneuropathy in dysautonomias.
N Engl J Med 336(10): 696-702, 1997. [Text Abstract on PubMed]
76 Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO.
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women.
Circulation 96(9): 2795-801, 1997. [Text Abstract on PubMed]
77 Koh KK, Bui MN, Mincemoyer R, Cannon RO.
Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
Am J Cardiol 80(11): 1505-7, 1997. [Text Abstract on PubMed]
78 Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO.
Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
N Engl J Med 336(10): 683-90, 1997. [Text Abstract on PubMed]
79 Laurienzo JM, Cannon RO, Quyyumi AA, Dilsizian V, Panza JA.
Improved specificity of transesophageal dobutamine stress echocardiography compared to standard tests for evaluation of coronary artery disease in women presenting with chest pain.
Am J Cardiol 80(11): 1402-7, 1997. [Text Abstract on PubMed]
80 Panza JA, Laurienzo JM, Curiel RV, Unger EF, Quyyumi AA, Dilsizian V, Cannon RO.
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography.
J Am Coll Cardiol 29(2): 293-301, 1997. [Text Abstract on PubMed]
81 Quyyumi AA, Dakak N, Diodati JG, Gilligan DM, Panza JA, Cannon RO.
Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation.
J Am Coll Cardiol 30(5): 1220-7, 1997. [Text Abstract on PubMed]
82 Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO.
Nitric oxide activity in the atherosclerotic human coronary circulation.
J Am Coll Cardiol 29(2): 308-17, 1997. [Text Abstract on PubMed]
83 Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO.
Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.
Circulation 95(1): 104-10, 1997. [Text Abstract on PubMed]
84 Cannon RO, Lesch M.
The search for a better exercise test. A self-fulfilling prophecy?
Circulation 93(2): 205-7, 1996. [Text Abstract on PubMed]
85 Cannon RO.
The heart in hypertension. Thinking small.
Am J Hypertens 9(4 Pt 1): 406-8, 1996. [Text Abstract on PubMed]
86 Guetta V, Cannon RO.
Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women.
Circulation 93(10): 1928-37, 1996. [Text Abstract on PubMed]
87 Cannon RO.
Chest pain and the sensitive heart.
Eur J Gastroenterol Hepatol 7(12): 1161-71, 1995. [Text Abstract on PubMed]
88 Cannon RO.
The sensitive heart. A syndrome of abnormal cardiac pain perception.
JAMA 273(11): 883-7, 1995. [Text Abstract on PubMed]
89 Casino PR, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA.
Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor.
Am J Cardiol 75(1): 40-4, 1995. [Text Abstract on PubMed]
90 Dakak N, Quyyumi AA, Eisenhofer G, Goldstein DS, Cannon RO.
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease.
Am J Cardiol 76(3): 125-30, 1995. [Text Abstract on PubMed]
91 Diodati JG, Cannon RO, Hussain N, Quyyumi AA.
Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris.
Am J Cardiol 75(7): 443-8, 1995. [Text Abstract on PubMed]
92 García CE, Kilcoyne CM, Cardillo C, Cannon RO, Quyyumi AA, Panza JA.
Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension.
Hypertension 26(6 Pt 1): 863-8, 1995. [Text Abstract on PubMed]
93 García CE, Kilcoyne CM, Cardillo C, Cannon RO, Quyyumi AA, Panza JA.
Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions.
Am J Cardiol 76(16): 1157-61, 1995. [Text Abstract on PubMed]
94 Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO.
Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
Am J Cardiol 75(4): 264-8, 1995. [Text Abstract on PubMed]
95 Guetta V, Lush RM, Figg WD, Waclawiw MA, Cannon RO.
Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women.
Am J Cardiol 76(14): 1072-3, 1995. [Text Abstract on PubMed]
96 Guetta V, Panza JA, Waclawiw MA, Cannon RO.
Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women.
Am J Cardiol 75(17): 1274-6, 1995. [Text Abstract on PubMed]
97 Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO.
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Circulation 91(6): 1732-8, 1995. [Text Abstract on PubMed]
98 Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO.
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Circulation 92(3): 320-6, 1995. [Text Abstract on PubMed]
99 Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO.
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
J Clin Invest 95(4): 1747-55, 1995. [Text Abstract on PubMed]
100 Cannon RO, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MA.
Imipramine in patients with chest pain despite normal coronary angiograms.
N Engl J Med 330(20): 1411-7, 1994. [Text Abstract on PubMed]
101 Cannon RO, Tripodi D, Dilsizian V, Panza JA, Fananapazir L.
Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy.
Am J Cardiol 73(8): 571-6, 1994. [Text Abstract on PubMed]
102 Diodati JG, Cannon RO, Quyyumi AA.
Platelet activation in stable coronary artery disease.
Am J Cardiol 73(6): 8B-11B, 1994. [Text Abstract on PubMed]
103 Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO.
Acute vascular effects of estrogen in postmenopausal women.
Circulation 90(2): 786-91, 1994. [Text Abstract on PubMed]
104 Gilligan DM, Guetta V, Panza JA, García CE, Quyyumi AA, Cannon RO.
Selective loss of microvascular endothelial function in human hypercholesterolemia.
Circulation 90(1): 35-41, 1994. [Text Abstract on PubMed]
105 Gilligan DM, Quyyumi AA, Cannon RO.
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.
Circulation 89(6): 2545-51, 1994. [Text Abstract on PubMed]
106 Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO.
Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia.
J Am Coll Cardiol 24(7): 1611-7, 1994. [Text Abstract on PubMed]
107 Panza JA, Laurienzo JM, Curiel RV, Quyyumi AA, Cannon RO.
Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease.
J Am Coll Cardiol 24(5): 1260-7, 1994. [Text Abstract on PubMed]
108 Sack MN, Rader DJ, Cannon RO.
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.
Lancet 343(8892): 269-70, 1994. [Text Abstract on PubMed]
109 Thomas DL, Cannon RO, Shapiro CN, Hook EW, Alter MJ, Quinn TC.
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.
J Infect Dis 169(5): 990-5, 1994. [Text Abstract on PubMed]
110 Cannon RO, Benjamin SB.
Chest pain as a consequence of abnormal visceral nociception.
Dig Dis Sci 38(2): 193-6, 1993. [Text Abstract on PubMed]
111 Cannon RO.
Chest pain with normal coronary angiograms.
N Engl J Med 328(23): 1706-8, 1993. [Text Abstract on PubMed]
112 Maron BJ, McIntosh CL, Klues HG, Cannon RO, Roberts WC.
Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy.
Am J Cardiol 71(12): 1089-94, 1993. [Text Abstract on PubMed]
113 Mautner GC, Mautner SL, Cannon RO, Hunsberger SA, Roberts WC.
Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular aortic stenosis.
Am J Cardiol 72(2): 194-8, 1993. [Text Abstract on PubMed]
114 Shirani J, Maron BJ, Cannon RO, Shahin S, Roberts WC.
Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation.
Am J Cardiol 72(5): 434-40, 1993. [Text Abstract on PubMed]
115 Cannon RO, Camici PG, Epstein SE.
Pathophysiological dilemma of syndrome X.
Circulation 85(3): 883-92, 1992. [Text Abstract on PubMed]
116 Diodati JG, Cannon RO, Epstein SE, Quyyumi AA.
Platelet hyperaggregability across the coronary bed in response to rapid atrial pacing in patients with stable coronary artery disease.
Circulation 86(4): 1186-93, 1992. [Text Abstract on PubMed]
117 Diodati JG, Schenke WH, Waclawiw MA, McIntosh CL, Cannon RO.
Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy.
Am J Cardiol 69(19): 1617-22, 1992. [Text Abstract on PubMed]
118 Eisenhofer G, Esler MD, Meredith IT, Dart A, Cannon RO, Quyyumi AA, Lambert G, Chin J, Jennings GL, Goldstein DS.
Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.
Circulation 85(5): 1775-85, 1992. [Text Abstract on PubMed]
119 Fananapazir L, Cannon RO, Tripodi D, Panza JA.
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
Circulation 85(6): 2149-61, 1992. [Text Abstract on PubMed]
120 Hook EW, Cannon RO, Nahmias AJ, Lee FF, Campbell CH, Glasser D, Quinn TC.
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals.
J Infect Dis 165(2): 251-5, 1992. [Text Abstract on PubMed]
121 Kaplan JE, Abrams E, Shaffer N, Cannon RO, Kaul A, Krasinski K, Bamji M, Hartley TM, Roberts B, Kilbourne B.
Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study.
J Infect Dis 166(4): 892-5, 1992. [Text Abstract on PubMed]
122 Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE.
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
N Engl J Med 326(6): 375-80, 1992. [Text Abstract on PubMed]
123 McIntosh CL, Maron BJ, Cannon RO, Klues HG.
Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
Circulation 86(5 Suppl): II60-7, 1992. [Text Abstract on PubMed]
124 Quyyumi AA, Cannon RO, Panza JA, Diodati JG, Epstein SE.
Endothelial dysfunction in patients with chest pain and normal coronary arteries.
Circulation 86(6): 1864-71, 1992. [Text Abstract on PubMed]
125 Roberts WC, Kishel JC, McIntosh CL, Cannon RO, Maron BJ.
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy.
J Am Coll Cardiol 19(2): 365-71, 1992. [Text Abstract on PubMed]
126 Rompalo AM, Cannon RO, Quinn TC, Hook EW.
Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection.
J Infect Dis 165(6): 1124-6, 1992. [Text Abstract on PubMed]
127 Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook EW, Blattner WA, Quinn TC.
Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
J Infect Dis 165(5): 920-4, 1992. [Text Abstract on PubMed]
128 Cannon RO, Poliner JR, Hirschhorn RB, Rodeheaver DC, Silverman PR, Brown EA, Talbot GH, Stine SE, Monroe SS, Dennis DT.
A multistate outbreak of Norwalk virus gastroenteritis associated with consumption of commercial ice.
J Infect Dis 164(5): 860-3, 1991. [Text Abstract on PubMed]
129 Cannon RO, Schenke WH, Quyyumi A, Bonow RO, Epstein SE.
Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina.
Circulation 83(5 Suppl): III77-81, 1991. [Text Abstract on PubMed]
130 Cannon RO.
Angina pectoris with normal coronary angiograms.
Cardiol Clin 9(1): 157-66, 1991. [Text Abstract on PubMed]
131 Cannon RO.
Microvascular angina. Cardiovascular investigations regarding pathophysiology and management.
Med Clin North Am 75(5): 1097-118, 1991. [Text Abstract on PubMed]
132 Clyne CA, Arrighi JA, Maron BJ, Dilsizian V, Bonow RO, Cannon RO.
Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis.
Am J Cardiol 68(15): 1469-76, 1991. [Text Abstract on PubMed]
133 Dilsizian V, Perrone-Filardi P, Cannon RO, Freedman NM, Bacharach SL, Bonow RO.
Comparison of exercise radionuclide angiography with thallium SPECT imaging for detection of significant narrowing of the left circumflex coronary artery.
Am J Cardiol 68(4): 320-8, 1991. [Text Abstract on PubMed]
134 Epstein SE, Cannon RO, Bonow RO.
Exercise testing in patients with microvascular angina.
Circulation 83(5 Suppl): III73-6, 1991. [Text Abstract on PubMed]
135 Fananapazir L, Leon MB, Bonow RO, Tracy CM, Cannon RO, Epstein SE.
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
Am J Cardiol 67(2): 169-74, 1991. [Text Abstract on PubMed]
136 Goldstein DS, Cannon RO, Quyyumi A, Chang P, Duncan M, Brush JE, Eisenhofer G.
Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.
J Auton Nerv Syst 34(1): 17-35, 1991. [Text Abstract on PubMed]
137 Maron BJ, Leon MB, Swain JA, Cannon RO, Pelliccia A.
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva.
Am J Cardiol 68(1): 140-2, 1991. [Text Abstract on PubMed]
138 Roberts CS, Gertz SD, Klues HG, Cannon RO, Maron BJ, McIntosh CL, Roberts WC.
Appearance of or persistence of severe mitral regurgitation without left ventricular outflow obstruction after partial ventricular septal myotomy-myectomy in hypertrophic cardiomyopathy.
Am J Cardiol 68(17): 1726-8, 1991. [Text Abstract on PubMed]
139 Roberts CS, McIntosh CL, Brown PS, Cannon RO, Gertz SD, Clark RE.
Reoperation for persistent outflow obstruction in hypertrophic cardiomyopathy.
Ann Thorac Surg 51(3): 455-60, 1991. [Text Abstract on PubMed]
140 Rostand SG, Brunzell JD, Cannon RO, Victor RG.
Cardiovascular complications in renal failure.
J Am Soc Nephrol 2(6): 1053-62, 1991. [Text Abstract on PubMed]
141 Cannon RO, Brush JE, Schenke WH, Tracy CM, Epstein SE.
Beneficial and detrimental effects of lidoflazine in microvascular angina.
Am J Cardiol 66(1): 37-41, 1990. [Text Abstract on PubMed]
142 Cannon RO, Cattau EL, Yakshe PN, Maher K, Schenke WH, Benjamin SB, Epstein SE.
Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries.
Am J Med 88(3): 217-22, 1990. [Text Abstract on PubMed]
143 Cannon RO, Peden DB, Berkebile C, Schenke WH, Kaliner MA, Epstein SE.
Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness.
Circulation 82(6): 2011-7, 1990. [Text Abstract on PubMed]
144 Cannon RO, Quyyumi AA, Schenke WH, Fananapazir L, Tucker EE, Gaughan AM, Gracely RH, Cattau EL, Epstein SE.
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries.
J Am Coll Cardiol 16(6): 1359-66, 1990. [Text Abstract on PubMed]
145 Cannon RO.
Chest pain with normal coronary angiograms: is the heart innocent or guilty?
J Am Coll Cardiol 16(3): 596-8, 1990. [Text Abstract on PubMed]
146 Hartley TM, Khabbaz RF, Cannon RO, Kaplan JE, Lairmore MD.
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays.
J Clin Microbiol 28(4): 646-50, 1990. [Text Abstract on PubMed]
147 Quinn TC, Cannon RO, Glasser D, Groseclose SL, Brathwaite WS, Fauci AS, Hook EW.
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics.
Arch Intern Med 150(6): 1297-302, 1990. [Text Abstract on PubMed]
148 Reinhart RA, Fananapazir L, Cannon RO, Hosseini JM, Elin RJ.
Effect of intravenous magnesium sulfate on blood magnesium parameters.
Magnes Trace Elem 9(4): 191-7, 1990. [Text Abstract on PubMed]
149 Udelson JE, Bacharach SL, Cannon RO, Bonow RO.
Minimum left ventricular pressure during beta-adrenergic stimulation in human subjects. Evidence for elastic recoil and diastolic "suction" in the normal heart.
Circulation 82(4): 1174-82, 1990. [Text Abstract on PubMed]
150 Brush JE, Eisenhofer G, Garty M, Stull R, Maron BJ, Cannon RO, Panza JA, Epstein SE, Goldstein DS.
Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy.
Circulation 79(4): 836-44, 1989. [Text Abstract on PubMed]
151 Brush JE, Udelson JE, Bacharach SL, Cannon RO, Leon MB, Rumble TF, Bonow RO.
Comparative effects of verapamil and nitroprusside on left ventricular function in patients with hypertension.
J Am Coll Cardiol 14(2): 515-22, 1989. [Text Abstract on PubMed]
152 Cannon RO, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE.
Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy.
Circulation 79(4): 766-75, 1989. [Text Abstract on PubMed]
153 Cannon RO.
Aminophylline for angina: the "Robin Hood" effect?
J Am Coll Cardiol 14(6): 1454-5, 1989. [Text Abstract on PubMed]
154 Cannon RO.
Coronary flow reserve in patients with chest pain, angiographically normal coronary arteries and normal left ventricle, dilated cardiomyopathy, and hypertrophic cardiomyopathy.
Bibl Cardiol(44): 25-38; discussion 38-9, 1989. [Text Abstract on PubMed]
155 Cooper MM, Tucker E, McIntosh CL, Cannon RO, Clark RE.
Effect of left ventricular septal myectomy on concurrent mitral regurgitation.
Ann Thorac Surg 48(2): 251-6, 1989. [Text Abstract on PubMed]
156 Dilsizian V, Cannon RO, Tracy CM, McIntosh CL, Clark RE, Bonow RO.
Enhanced regional left ventricular function after distant coronary bypass by means of improved collateral blood flow.
J Am Coll Cardiol 14(2): 312-8, 1989. [Text Abstract on PubMed]
157 Eisenhofer G, Brush JE, Cannon RO, Stull R, Kopin IJ, Goldstein DS.
Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
J Clin Endocrinol Metab 68(2): 247-55, 1989. [Text Abstract on PubMed]
158 Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO, Bonow RO, Maron BJ, Epstein SE.
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.
Circulation 80(5): 1259-68, 1989. [Text Abstract on PubMed]
159 Kaplan JE, Yamamura Y, Ríos-Olivares EO, Cannon RO, Khabbaz RF, Gubler DJ, Kaiselburd EN, Hartley TM, Lairmore MD.
Seroprevalence of human T lymphotropic virus type I in Puerto Rico.
Am J Trop Med Hyg 40(6): 659-62, 1989. [Text Abstract on PubMed]
160 McIntosh CL, Greenberg GJ, Maron BJ, Leon MB, Cannon RO, Clark RE.
Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy.
Ann Thorac Surg 47(2): 236-46, 1989. [Text Abstract on PubMed]
161 Pace L, Bacharach SL, Bonow RO, Cannon RO, Green MV, Larson SM.
Diagnosis of coronary artery disease by radionuclide angiography: effect of combining indices of left ventricular function.
J Nucl Med 30(12): 1966-71, 1989. [Text Abstract on PubMed]
162 Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO, Alling D.
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy.
N Engl J Med 321(16): 1061-8, 1989. [Text Abstract on PubMed]
163 Roy-Byrne PP, Schmidt P, Cannon RO, Diem H, Rubinow DR.
Microvascular angina and panic disorder.
Int J Psychiatry Med 19(4): 315-25, 1989. [Text Abstract on PubMed]
164 Udelson JE, Cannon RO, Bacharach SL, Rumble TF, Bonow RO.
Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comparison to rapid atrial pacing.
Circulation 79(2): 371-82, 1989. [Text Abstract on PubMed]
165 Betocchi S, Bonow RO, Cannon RO, Lesko LJ, Ostrow HG, Watson RM, Rosing DR.
Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy.
Am J Cardiol 61(10): 830-5, 1988. [Text Abstract on PubMed]
166 Bonow RO, Maron BJ, Leon MB, Cannon RO, Epstein SE.
Medical and surgical therapy of hypertrophic cardiomyopathy.
Cardiovasc Clin 19(1): 221-39, 1988. [Text Abstract on PubMed]
167 Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE.
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.
N Engl J Med 319(20): 1302-7, 1988. [Text Abstract on PubMed]
168 Cannon RO, Epstein SE.
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries.
Am J Cardiol 61(15): 1338-43, 1988. [Text Abstract on PubMed]
169 Cannon RO.
Acetylcholine and coronary artery spasm: important insight or squeeze play?
J Am Coll Cardiol 12(4): 889-91, 1988. [Text Abstract on PubMed]
170 Cannon RO.
Causes of chest pain in patients with normal coronary angiograms: the eye of the beholder.
Am J Cardiol 62(4): 306-8, 1988. [Text Abstract on PubMed]
171 Dilsizian V, Bonow RO, Cannon RO, Tracy CM, Vitale DF, McIntosh CL, Clark RE, Bacharach SL, Green MV.
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia.
Am J Cardiol 61(15): 1248-54, 1988. [Text Abstract on PubMed]
172 Potkin BN, McIntosh CL, Cannon RO, Roberts WC.
Bioprostheses in tricuspid and mitral valve positions for 100 months with heavier calcific deposits on the left-sided valve followed by new bioprostheses in both positions for 95 months with heavier calcific deposits on the right-sided valve.
Am J Cardiol 61(11): 947-9, 1988. [Text Abstract on PubMed]
173 Quinn TC, Glasser D, Cannon RO, Matuszak DL, Dunning RW, Kline RL, Campbell CH, Israel E, Fauci AS, Hook EW.
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases.
N Engl J Med 318(4): 197-203, 1988. [Text Abstract on PubMed]
174 Cannon RO, Cunnion RE, Parrillo JE, Palmeri ST, Tucker EE, Schenke WH, Epstein SE.
Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.
J Am Coll Cardiol 10(6): 1190-200, 1987. [Text Abstract on PubMed]
175 Cannon RO, Schenke WH, Leon MB, Rosing DR, Urqhart J, Epstein SE.
Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
Circulation 75(1): 163-74, 1987. [Text Abstract on PubMed]
176 Cannon RO, Schenke WH, Maron BJ, Tracy CM, Leon MB, Brush JE, Rosing DR, Epstein SE.
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.
J Am Coll Cardiol 10(1): 53-62, 1987. [Text Abstract on PubMed]
177 Cannon RO.
Myocardial ischemia in hypertrophic cardiomyopathy.
Z Kardiol 76 Suppl 3: 101-4, 1987. [Text Abstract on PubMed]
178 Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE.
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).
N Engl J Med 316(13): 780-9, 1987. [Text Abstract on PubMed]
179 Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE.
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2).
N Engl J Med 316(14): 844-52, 1987. [Text Abstract on PubMed]
180 Rosing DR, Cannon RO, Watson RM, Bonow RO, Mincemoyer R, Ewels C, Leon MB, Lakatos E, Epstein SE, Kent KM.
Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty.
J Am Coll Cardiol 9(1): 1-7, 1987. [Text Abstract on PubMed]
181 Sax FL, Cannon RO, Hanson C, Epstein SE.
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function?
N Engl J Med 317(22): 1366-70, 1987. [Text Abstract on PubMed]
182 Cannon RO, Schenke WH, Bonow RO, Leon MB, Rosing DR.
Left ventricular pulsus alternans in patients with hypertrophic cardiomyopathy and severe obstruction to left ventricular outflow.
Circulation 73(2): 276-85, 1986. [Text Abstract on PubMed]
183 Cannon RO.
Angina pectoris with angiographically normal coronary arteries: a clinical, hemodynamic, and metabolic study.
Clin Cardiol 9(2): A7, A16, 1986. [Text Abstract on PubMed]
184 Epstein SE, Cannon RO.
Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries.
J Am Coll Cardiol 8(2): 459-61, 1986. [Text Abstract on PubMed]
185 Goldstein DS, Bonner RF, Zimlichman R, Zahn TP, Cannon RO, Rosing DR, Stull R, Keiser HR.
Indices of sympathetic vascular innervation in sympathectomized patients.
J Auton Nerv Syst 15(4): 309-18, 1986. [Text Abstract on PubMed]
186 Goldstein DS, Cannon RO, Zimlichman R, Keiser HR.
Clinical evaluation of impedance cardiography.
Clin Physiol 6(3): 235-51, 1986. [Text Abstract on PubMed]
187 Betocchi S, Cannon RO, Watson RM, Bonow RO, Ostrow HG, Epstein SE, Rosing DR.
Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
Circulation 72(5): 1001-7, 1985. [Text Abstract on PubMed]
188 Cannon RO, Bonow RO, Bacharach SL, Green MV, Rosing DR, Leon MB, Watson RM, Epstein SE.
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve.
Circulation 71(2): 218-26, 1985. [Text Abstract on PubMed]
189 Cannon RO, Leon MB, Watson RM, Rosing DR, Epstein SE.
Chest pain and "normal" coronary arteries--role of small coronary arteries.
Am J Cardiol 55(3): 50B-60B, 1985. [Text Abstract on PubMed]
190 Cannon RO, Rodríguez ER, Speir E, Yamaguchi M, Butany J, McManus BM, Bolli R, Ferrans VJ.
Effect of ibuprofen on the healing phase of experimental myocardial infarction in the rat.
Am J Cardiol 55(13 Pt 1): 1609-13, 1985. [Text Abstract on PubMed]
191 Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE.
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
Circulation 71(2): 234-43, 1985. [Text Abstract on PubMed]
192 Cannon RO, Rosing DR.
Evaluation of myocardial function by invasive methods.
Cardiovasc Clin 15(1): 127-40, 1985. [Text Abstract on PubMed]
193 Cannon RO, Watson RM, Rosing DR, Epstein SE.
Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve.
Am J Cardiol 56(4): 242-6, 1985. [Text Abstract on PubMed]
194 Cannon RO.
Myocardial ischemia due to dynamic small vessel coronary artery disease.
Int J Cardiol 7(2): 198-203, 1985. [Text Abstract on PubMed]
195 Epstein SE, Cannon RO, Talbot TL.
Hemodynamic principles in the control of coronary blood flow.
Am J Cardiol 56(9): 4E-10E, 1985. [Text Abstract on PubMed]
196 Epstein SE, Cannon RO, Watson RM, Leon MB, Bonow RO, Rosing DR.
Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy.
Am J Cardiol 55(3): 61B-68B, 1985. [Text Abstract on PubMed]
197 Ciró E, Maron BJ, Bonow RO, Cannon RO, Epstein SE.
Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy.
Am J Cardiol 53(8): 1103-9, 1984. [Text Abstract on PubMed]
198 Silver MA, Bonow RO, Deglin SM, Maron BJ, Cannon RO, Roberts WC.
Acquired left ventricular endocardial constriction from massive mural calcific deposits: a newly recognized cause of impairment to left ventricular filling.
Am J Cardiol 53(10): 1468-70, 1984. [Text Abstract on PubMed]
199 Bolli R, Cannon RO, Speir E, Goldstein RE, Epstein SE.
Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
J Am Coll Cardiol 2(4): 671-80, 1983. [Text Abstract on PubMed]
200 Bolli R, Cannon RO, Speir E, Goldstein RE, Epstein SE.
Role of cellular proteinases in acute myocardial infarction. II. Influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat.
J Am Coll Cardiol 2(4): 681-8, 1983. [Text Abstract on PubMed]
201 Bonow RO, Ostrow HG, Rosing DR, Cannon RO, Lipson LC, Maron BJ, Kent KM, Bacharach SL, Green MV.
Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
Circulation 68(5): 1062-73, 1983. [Text Abstract on PubMed]
202 Cannon RO, Butany JW, McManus BM, Speir E, Kravitz AB, Bolli R, Ferrans VJ.
Early degradation of collagen after acute myocardial infarction in the rat.
Am J Cardiol 52(3): 390-5, 1983. [Text Abstract on PubMed]
203 Cannon RO, Watson RM, Rosing DR, Epstein SE.
Angina caused by reduced vasodilator reserve of the small coronary arteries.
J Am Coll Cardiol 1(6): 1359-73, 1983. [Text Abstract on PubMed]
204 Springer RM, Gheorghiade M, Chakko CS, Bell GM, Cannon RO, Urquhart J, Jones M, Bonow RO.
Platypnea and interatrial right-to-left shunting after lobectomy.
Am J Cardiol 51(10): 1802-3, 1983. [Text Abstract on PubMed]
205 Cannon RO, Dusheiko GM, Long JA, Ishak KG, Kapur S, Anderson KD, Nienhuis AW.
Hepatocellular adenoma in a young woman with beta-thalassemia and secondary iron overload.
Gastroenterology 81(2): 352-5, 1981. [Text Abstract on PubMed]
206 Beyt BE, Cannon RO, Tuteur PG.
Successful treatment of invasive pulmonary aspergillosis in the immunocompromised host.
South Med J 71(9): 1164-6, 1978. [Text Abstract on PubMed]
207 FERGUSON ME, BRIDGFORTH E, QUAIFE ML, MARTIN MP, CANNON RO, McGANITY WJ, NEWBILL J, DARBY WJ.
The Vanderbilt cooperative study of maternal and infant nutrition. VII. Tocopherol in relation to pregnancy.
J Nutr 55(2): 305-21, 1955. [Text Abstract on PubMed]
208 McGANITY WJ, CANNON RO, BRIDGFORTH EB, MARTIN MP, DENSEN PM, NEWBILL JA, McCLELLAN GS, CHRISTIE A, PETERSON JC, DARBY WJ.
The Vanderbilt cooperative study of maternal and infant nutrition. V. Description and outcome of obstetric sample.
Am J Obstet Gynecol 67(3): 491-500, 1954. [Text Abstract on PubMed]
209 McGANITY WJ, CANNON RO, BRIDGFORTH EB, MARTIN MP, DENSEN PM, NEWBILL JA, McCLELLAN GS, CHRISTIE A, PETERSON JC, DARBY WJ.
The Vanderbilt cooperative study of maternal and infant nutrition. VI. Relationship of obstetric performance to nutrition.
Am J Obstet Gynecol 67(3): 501-27, 1954. [Text Abstract on PubMed]
210 DARBY WJ, DENSEN PM, CANNON RO, BRIDGFORT E, MARTIN MP, KASER MM, PETERSON C, CHRISTIE A, FRYE WW, JUSTUS K, McCLELLAN GS, WILLIAMS C, OGLE PJ, HAHN PF, SHEPPARD CW, CAROTHERS EL, NEWBILL JA.
The Vanderbilt cooperative study of maternal and infant nutrition. I. Background. II. Methods. III. Description of the sample and data.
J Nutr 51(4): 539-63, 1953. [Text Abstract on PubMed]
211 DARBY WJ, McGANITY WJ, MARTIN MP, BRIDGFORT E, DENSEN PM, KASER MM, OGLE PJ, NEWBILL JA, STOCKELL A, FERGUSON ME, TOUSTER O, McCLELLAN GS, WILLIAMS C, CANNON RO.
The Vanderbilt cooperative study of maternal and infant nutrition. IV. Dietary, laboratory and physical findings in 2,129 delivered pregnancies.
J Nutr 51(4): 565-97, 1953. [Text Abstract on PubMed]
212 CANNON RO.
Methods of financing the university hospitals.
South Med J 45(8): 764-6, 1952. [Text Abstract on PubMed]
213 HAHN PF, CAROTHERS EL, DARBY WJ, MARTIN M, SHEPPARD CW, CANNON RO, BEAM AS, DENSEN PM, PETERSON JC, McCLELLAN GS.
Iron metabolism in human pregnancy as studied with radioactive isotope, Fe59.
Am J Obstet Gynecol 61(3): 477-86, 1951. [Text Abstract on PubMed]
214 Cannon RO, Schmid GP, Moore PS, Pappaioanou M.
Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985-1987.
Sex Transm Dis 16(4): 184-9, [Text Abstract on PubMed]
215 Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function.
Circulation 99(1): 90-5, [Text Abstract on PubMed]